Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Inglês | LILACS | ID: biblio-1529389

RESUMO

Abstract Objectives: to determine efficiency and safety of three misoprostol regimens for 2nd trimester pregnancy termination in individuals with two or more cesarean section scars. Methods: a cross-sectional study included 100 pregnant ladies at 13th-26th weeks gestation with previous two cesarean sections (CSs) who were scheduled for pregnancy termination using misoprostol. Patients were conveniently assigned to 100µg/3h, 200µg/3h or 400 µg/3h regimens. Primary outcome was time to abortion, secondary outcomes were side effect and complications. Results: a significant association was found between number previous CSs and longer time to abortion (p=0.01). A highly significant association was identified between earlier gestational age and longer time to abortion (p<0.001). Lower side effects and complications were associated with 200 µg misoprostol every 3 hours of (p<0.001). Incomplete abortion was the most frequent recorded complication for the successive doses of misoprostol. Conclusions: misoprostol is an effective drug at low doses for pregnancy termination in women with prior two or more caesarean sections. However, its safety needs monitoring of the patient in the hospital to decrease morbidity and mortality behind its use.


Resumo Objetivos: determinar a eficiência e segurança de três regimes de misoprostol para interrupção da gravidez no segundo trimestre em indivíduos com duas ou mais cicatrizes de cesariana. Métodos: um estudo transversal incluiu 100 gestantes entre 13ª e 26ª semanas de gestação com duas cesarianas (CEs) anteriores que foram agendadas para interrupção da gravidez com uso de misoprostol. Os pacientes foram convenientemente designados para regimes de 100 µg/3 horas, 200 µg/3 horas ou 400 µg/3 horas. O desfecho primário foi o tempo para o aborto, os desfechos secundários foram efeitos colaterais e complicações. Resultados: foi encontrada associação significativa entre o número de cesáreas anteriores e o maior tempo até o aborto (p=0,01). Foi identificada associação altamente significativa entre idade gestacional mais precoce e maior tempo para abortar (p<0,001). Menores efeitos colaterais e complicações foram associados com 200 µg de misoprostol a cada 3 horas (p<0,001). O aborto incompleto foi a complicação mais frequente registrada para as doses sucessivas de misoprostol. Conclusões: o misoprostol é um medicamento eficaz em doses baixas para interrupção da gravidez em mulheres com duas ou mais cesarianas anteriores. Porém, sua segurança necessita de monitoramento do paciente no hospital para diminuir a morbimortalidade por trás de seu uso.


Assuntos
Humanos , Feminino , Gravidez , Segundo Trimestre da Gravidez , Misoprostol/administração & dosagem , Aborto Induzido , Recesariana , Estudos Transversais
2.
Prensa méd. argent ; 105(7): 410-415, agosto 2019. tab, graf
Artigo em Inglês | BINACIS, LILACS | ID: biblio-1022189

RESUMO

Bachkgrond: Anemia is a very important nutritional disorder in the world, it has multiple etiologies and pregnancy is associated with a deficit in the intake of iron and physiological changes of pregnancy. Aim of the study: To assess the prevalence of anemia in pregnant Iraqi women. Patients and method: A cross-sectional study carried at Al-Elwyia maternity teaching hospital in the period from the 1st of Jan. 2018 to the end of October 2018, in which 1000 pregnant women were enrolled in the study and divided into 2 groups: case group (n=652) and control group (n=348) according to the level of Hb. Results: The mean age of the case group was (27.8±7.1) years old and (26.1±2.3) years for the control group. The anemia was found in (6521000) patients and Iron deficiency anemia is the main type of anemia (80.2%) while (19.8%) was another type of anemia. Poor diet (65%) is the common cause of anemia were found commonly in the 3rd trimester (50.2%). Conclusion: The prevalence of anemia was 65.2% in the current study (AU)


Assuntos
Humanos , Feminino , Gravidez , Adulto , Terceiro Trimestre da Gravidez , Hemoglobinas/deficiência , Gravidez , Estudos de Casos e Controles , Declaração de Helsinki , Anemia/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA